CTLA4 and central nervous system cancer: The expression of CTLA-4 in glioma specimens of patients who underwent neurosurgical resection indicated that higher CTLA-4 expression in the tumor microenvironment resulted in greater immune cell infiltration and correlated with a shorter overall survival [41].